Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 300

1.

Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG-GEFI encoding gene.

Desai A, Bergmeier W, Canault M, Alessi MC, Paul DS, Nurden P, Pillois X, Jy W, Ahn YS, Nurden AT.

Res Pract Thromb Haemost. 2017 Jun 20;1(1):128-133. doi: 10.1002/rth2.12019. eCollection 2017 Jul.

2.

From Naproxen Repurposing to Naproxen Analogues and Their Antiviral Activity against Influenza A Virus.

Dilly S, Fotso Fotso A, Lejal N, Zedda G, Chebbo M, Rahman F, Companys S, Bertrand HC, Vidic J, Noiray M, Alessi MC, Tarus B, Quideau S, Riteau B, Slama-Schwok A.

J Med Chem. 2018 Aug 23;61(16):7202-7217. doi: 10.1021/acs.jmedchem.8b00557. Epub 2018 Aug 3.

3.

The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.

Rahman F, Chebbo M, Courtin N, Fotso Fotso A, Alessi MC, Riteau B.

Int J Mol Sci. 2018 May 8;19(5). pii: E1400. doi: 10.3390/ijms19051400.

4.

Anti-αIIb β3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations.

Fiore M, d'Oiron R, Pillois X, Alessi MC.

Br J Haematol. 2018 Apr;181(2):173-182. doi: 10.1111/bjh.15087. Epub 2018 Apr 2. Review.

PMID:
29611179
5.

Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.

Saultier P, Szepetowski S, Canault M, Falaise C, Poggi M, Suchon P, Barlogis V, Michel G, Loyau S, Jandrot-Perrus M, Bordet JC, Alessi MC, Chambost H.

Haematologica. 2018 Jun;103(6):e264-e267. doi: 10.3324/haematol.2017.186304. Epub 2018 Feb 22. No abstract available.

6.

Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.

Deharo P, Quilici J, Camoin-Jau L, Johnson TW, Bassez C, Bonnet G, Fernandez M, Ibrahim M, Suchon P, Verdier V, Fourcade L, Morange PE, Bonnet JL, Alessi MC, Cuisset T.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2560-2570. doi: 10.1016/j.jcin.2017.08.044.

7.

Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.

Lê VB, Riteau B, Alessi MC, Couture C, Jandrot-Perrus M, Rhéaume C, Hamelin MÈ, Boivin G.

Br J Pharmacol. 2018 Jan;175(2):388-403. doi: 10.1111/bph.14084. Epub 2017 Dec 10.

PMID:
29105740
8.

Mutations of the integrin αIIb/β3 intracytoplasmic salt bridge cause macrothrombocytopenia and enlarged platelet α-granules.

Favier M, Bordet JC, Favier R, Gkalea V, Pillois X, Rameau P, Debili N, Alessi MC, Nurden P, Raslova H, Nurden A.

Am J Hematol. 2018 Feb;93(2):195-204. doi: 10.1002/ajh.24958. Epub 2017 Nov 17.

PMID:
29090484
9.

A new heterozygous mutation in GP1BA gene responsible for macrothrombocytopenia.

Ghalloussi D, Saut N, Bernot D, Pillois X, Rameau P, Sébahoun G, Alessi MC, Raslova H, Baccini V.

Br J Haematol. 2018 Nov;183(3):503-506. doi: 10.1111/bjh.14986. Epub 2017 Oct 30. No abstract available.

PMID:
29082515
10.

Peripartum bleeding management in a patient with CalDAG-GEFI deficiency.

Canault M, Saultier P, Fauré S, Poggi M, Nurden AT, Nurden P, Morange PE, Alessi MC, Gris JC.

Haemophilia. 2017 Nov;23(6):e533-e535. doi: 10.1111/hae.13352. Epub 2017 Oct 4. No abstract available.

PMID:
28976076
11.

Assessment of platelet function on the routine coagulation analyzer Sysmex CS-2000i.

Frère C, Kobayashi K, Dunois C, Amiral J, Morange PE, Alessi MC.

Platelets. 2018 Jan;29(1):95-97. doi: 10.1080/09537104.2017.1353683. Epub 2017 Sep 29.

12.

FPR2: A Novel Promising Target for the Treatment of Influenza.

Alessi MC, Cenac N, Si-Tahar M, Riteau B.

Front Microbiol. 2017 Sep 5;8:1719. doi: 10.3389/fmicb.2017.01719. eCollection 2017. Review.

13.

Hematopoietic stem cell transplantation for the treatment of leukocyte adhesion deficiency type III.

Saultier P, Alessi MC, Michel G, Chambost H.

Pediatr Neonatol. 2017 Dec;58(6):560-561. doi: 10.1016/j.pedneo.2017.07.006. Epub 2017 Jul 24. No abstract available.

14.

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding.

Westbury SK, Canault M, Greene D, Bermejo E, Hanlon K, Lambert MP, Millar CM, Nurden P, Obaji SG, Revel-Vilk S, Van Geet C, Downes K, Papadia S, Tuna S, Watt C; NIHR BioResource–Rare Diseases Consortium, Freson K, Laffan MA, Ouwehand WH, Alessi MC, Turro E, Mumford AD.

Blood. 2017 Aug 24;130(8):1026-1030. doi: 10.1182/blood-2017-03-776773. Epub 2017 Jun 21.

15.

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.

Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert M, Verdier V, Morange PE, Alessi MC, Bonnet JL.

Eur Heart J. 2017 Nov 1;38(41):3070-3078. doi: 10.1093/eurheartj/ehx175.

PMID:
28510646
16.

Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.

Courtin N, Fotso AF, Fautrad P, Mas F, Alessi MC, Riteau B.

Antiviral Res. 2017 Jul;143:252-261. doi: 10.1016/j.antiviral.2017.05.001. Epub 2017 May 5.

17.

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.

Suchon P, Germain M, Delluc A, Smadja D, Jouven X, Gyorgy B, Saut N, Ibrahim M, Deleuze JF, Alessi MC, Morange PE, Trégouët DA.

Sci Rep. 2017 Apr 4;7:45507. doi: 10.1038/srep45507.

18.

Macrothrombocytopenia and dense granule deficiency associated with FLI1 variants: ultrastructural and pathogenic features.

Saultier P, Vidal L, Canault M, Bernot D, Falaise C, Pouymayou C, Bordet JC, Saut N, Rostan A, Baccini V, Peiretti F, Favier M, Lucca P, Deleuze JF, Olaso R, Boland A, Morange PE, Gachet C, Malergue F, Fauré S, Eckly A, Trégouët DA, Poggi M, Alessi MC.

Haematologica. 2017 Jun;102(6):1006-1016. doi: 10.3324/haematol.2016.153577. Epub 2017 Mar 2.

19.

α1 -antitrypsin Pittsburgh and plasmin-mediated proteolysis.

Henneuse A, Suchon P, Chambost H, Morange PE, Frere C, Alessi MC.

J Thromb Haemost. 2016 Oct;14(10):2023-2026. doi: 10.1111/jth.13426. Epub 2016 Sep 2.

20.

Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors.

Poggi M, Canault M, Favier M, Turro E, Saultier P, Ghalloussi D, Baccini V, Vidal L, Mezzapesa A, Chelghoum N, Mohand-Oumoussa B, Falaise C, Favier R, Ouwehand WH, Fiore M, Peiretti F, Morange PE, Saut N, Bernot D, Greinacher A, BioResource N, Nurden AT, Nurden P, Freson K, Trégouët DA, Raslova H, Alessi MC.

Haematologica. 2017 Feb;102(2):282-294. doi: 10.3324/haematol.2016.147694. Epub 2016 Sep 23.

Supplemental Content

Loading ...
Support Center